Delpharm

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40018490

Informations générales

Localisation

France

Europe

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

27/11/2025

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon FY2030

Statut

Targets set

Classification

1.5°C

Année cible

FY2030

Progression vers l'objectif0%
2015 (année de référence)FY2030
Description complète des objectifs

Near-Term Targets: Delpharm commits to reduce absolute scope 1 and 2 GHG emissions 42.0% by FY2030 from a FY2023 base year. Delpharm also commits to reduce absolute scope 3 GHG emissions from purchased goods and services, waste generated in operations and business travel 25.0% within the same timeframe.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Source : Science Based Targets initiative | Données publiques